EUCTR2009-017711-15-NL进行中（未招募）不适用
SYMPTOMATIC IMPROVEMENT BY PERITONEAL DIALYSIS IN PATIENTS WITH END STAGE CONGESTIVE HEART FAILURE - PD in CHF
Martini Ziekenhuis Groningen0 个研究点开始时间: 2011年1月5日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Age > 18 years.
- •2. Refractory Left Ventricular Congestive Heart Failure: LVEF < 30%.
- •3. Diminished renal function: eGFR < 45 ml/min.
- •4. Clinically volume overloaded (Dyspnoea (NYHA III-IV), edema, and/or ascites)
- •5. Hospitalization for CHF during the last 6 months.
- •6. Patient is on optimal cardiologic medical therapy, which has been stable for more than 4 weeks
- •7. Suitable for PD.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Hypotension (SBP < 100 mmHg / MAP < 70) mmHg
- •2. Instable AP or recent (< 6 months) myocardial infarction.
- •3. Contraindications for PD (e.g. visual handicap, social)
- •4. Liver failure
- •5. COPD Gold class IV
- •6. Malignancy with life expectancy < 2 years
- •7. Non compliance
- •8. No informed consent
- •9. Poor mental health
研究者
相似试验
已完成
3 期
SYMPTOMATIC IMPROVEMENT BY PERITONEAL DIALYSIS IN PATIENTS WITH END STAGE CONGESTIVE HEART FAILUREcardiac decompensation10019280heart failureNL-OMON38127Martini Ziekenhuis45
招募中
不适用
Reduction of peritoneal dialysis-related peritonitis by dental intervention at dialysis inductioPeritoneal dialysis-related peritonitisJPRN-UMIN000028782Matsuyama Red Cross Hospital50
尚未招募
3 期
Effects of Dialysate/Replacement Supraphysiologic Sodium Concentration and Hemodynamic Stability in Critically-ill Patients receiving Continuous Renal Replacement Therapy (CRRT) : A Randomized, Double-blinded, Controlled StudyCritically-ill patients requiring continuous renal replacement therapyContinuous renal replacement therapyContinuous venovenous hemofiltrationContinuous venovenous hemodiafiltrationReplacement fluidDialysis fluidTCTR20200108001Division of Nephrology, Department of Internal Medicine, Faculty of Medicine64
未知
3 期
Clinical Study in Peritoneal Dialysis PatientsChronic Kidney DiseaseJPRN-jRCT2080221395JAPAN TABACCO INC.50
已完成
不适用
Effect of the use of dialyzer having excellent performance for removal of cytokines on clinical observation in maintenance HD patientsHypercytokinemia in maintenance hemodialysis patientsJPRN-UMIN000010357Tokai Cytokine Removal Study Group20